BioWorld

May 8, 2008

View Archived Issues

ImaRx Shares Spike on Sale of Urokinase to Microbix

In a deal that sent shares of ImaRx Therapeutics Inc. soaring and spurred the creation of a spin-off company, Microbix Biosystems agreed to acquire urokinase inventory and related assets from ImaRx for $17 million in cash. (BioWorld Today) Read More

Enzon to Spin Off its Biotech, Forming 2 Public Companies

Read More

Spectrum Sale of Profit Shares of Migraine Drug Nets $20M

Read More

Good Data on Riquent in Hand, La Jolla Seeks $30M Offering

Read More

ACT Biotech is Born with Pipeline, $12M

Read More

Earnings Roundup

Read More

Other News To Note

Read More

Appointments And Advancements

Read More

Clinic Roundup

Read More